Nuo Therapeutics, Inc. (AURX)
USD 1.35
(-12.9%)
USD 1.35
(-12.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.16 Million | -3.7 Million | -13 Thousand | -9847.00 | -4168.00 | -874.38 Thousand |
| Net Income | -3.17 Million | -3.17 Million | -19.01 Thousand | -12.26 Thousand | -5721.00 | -1.54 Million |
| Depreciation & Amortization | 105.25 Thousand | 74.08 Thousand | - | - | 89.85 Thousand | 102.19 Thousand |
| Deferred income taxes | -21.74 Thousand | - | - | - | -359.54 Thousand | -210.15 Thousand |
| Stock-based compensation | 21.74 Thousand | 9145.00 | 13.93 Thousand | 333.62 Thousand | 50 Thousand | 7095.00 |
| Change in working capital | -299.42 Thousand | -471.17 Thousand | 6016.00 | 2420.00 | 1553.00 | 742.68 Thousand |
| Other non-cash items | 197.81 Thousand | -146.43 Thousand | -13.93 Billion | -333.62 Thousand | 219.68 Thousand | 25.61 Thousand |
| Investing Cash Flow | -7244.00 | -59.99 Thousand | - | - | - | 2000.00 |
| Investments in PPE | -7244.00 | -59.99 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | 2000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 2000.00 |
| Financing Cash Flow | 1.99 Million | 4.45 Million | 1373.09 Billion | 195 Thousand | 305 Thousand | 815.8 Thousand |
| Debt repayment | - | - | - | - | - | -315.8 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.99 Million | 4.45 Million | 1.37 Million | 195 Thousand | - | 500 Thousand |
| Other Financing Activities | 1.99 Million | 4.45 Million | 1373.09 Billion | 195 Thousand | 305 Thousand | 315.8 Thousand |
| Accounts receivables | -318.38 Thousand | -92.32 Thousand | - | - | 22.17 Thousand | 331.82 Thousand |
| Accounts payables | -3185.00 | 17.58 Thousand | 7516.00 | 3920.00 | 1553.00 | 57.04 Thousand |
| Inventory | 14.34 Thousand | -240 Thousand | - | - | 25.34 Thousand | -5320.00 |
| Other working capital | 7802.00 | -156.43 Thousand | -1500.00 | -1500.00 | -47.51 Thousand | 359.14 Thousand |
| Cash at beginning of period | 2.1 Million | 1.41 Million | 161.43 Thousand | 161.43 Thousand | 161.43 Thousand | 693.51 Thousand |
| Cash at end of period | 928.68 Thousand | 2.1 Million | 148.43 Thousand | 151.58 Thousand | 157.26 Thousand | 636.92 Thousand |
| Capital Expenditure | -7244.00 | -59.99 Thousand | - | - | - | - |
| Effect of forex changes on cash | -1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -1.17 Million | 691.63 Thousand | -13 Thousand | -9847.00 | -4168.00 | -56.58 Thousand |
| Free Cash Flow | -3.17 Million | -3.76 Million | -13 Thousand | -9847.00 | -4168.00 | -874.38 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -540.09 Thousand | -708.78 Thousand | -653.15 Thousand | -3.17 Million | -790.64 Thousand | -871.88 Thousand |
| Depreciation & Amortization | 19.89 Thousand | 27.52 Thousand | 26.99 Thousand | 105.25 Thousand | 26.39 Thousand | 26.01 Thousand |
| Deferred income taxes | - | - | -141.19 Thousand | -21.74 Thousand | - | -127.46 Thousand |
| Stock-based compensation | 3081.00 | 3081.00 | 3081.00 | 21.74 Thousand | 11.52 Thousand | 4718.00 |
| Change in working capital | -174.05 Thousand | 98.22 Thousand | -108.33 Thousand | -299.42 Thousand | -158.23 Thousand | -64.73 Thousand |
| Other non-cash items | 212.2 Thousand | -17.82 Thousand | 201.19 Thousand | 197.81 Thousand | 116.07 Thousand | 127.46 Thousand |
| Investing Cash Flow | -4100.00 | - | - | -7244.00 | -1901.00 | - |
| Investments in PPE | -4100.00 | - | - | -7244.00 | -1901.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 802.07 Thousand | - | 962.5 Thousand | 1.99 Million | 1.03 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 802.07 Thousand | - | 962.5 Thousand | 1.99 Million | 1.03 Million | - |
| Other Financing Activities | 802.07 Thousand | - | 962.5 Thousand | 1.99 Million | 1.03 Million | - |
| Accounts receivables | -75.2 Thousand | 3434.00 | -77.82 Thousand | -318.38 Thousand | -131.38 Thousand | -67.38 Thousand |
| Accounts payables | -88.68 Thousand | 91.8 Thousand | -6365.00 | -3185.00 | -35.25 Thousand | 10.54 Thousand |
| Inventory | -5443.00 | -1784.00 | 71.00 | 14.34 Thousand | 70.00 | -13.87 Thousand |
| Other working capital | -4727.00 | 4769.00 | -24.21 Thousand | 7802.00 | 8331.00 | 5973.00 |
| Cash at beginning of period | 366.23 Thousand | 928.68 Thousand | 637.58 Thousand | 2.1 Million | 399.37 Thousand | 1.3 Million |
| Cash at end of period | 473.04 Thousand | 366.23 Thousand | 928.68 Thousand | 928.68 Thousand | 637.58 Thousand | 399.37 Thousand |
| Capital Expenditure | -4100.00 | - | - | -7244.00 | -1901.00 | - |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | 106.8 Thousand | -562.44 Thousand | 291.09 Thousand | -1.17 Million | 238.21 Thousand | -905.89 Thousand |
| Free Cash Flow | -695.26 Thousand | -562.44 Thousand | -671.4 Thousand | -3.17 Million | -796.78 Thousand | -905.89 Thousand |
TREAY
EQUITASBNK
GLATF
IOB
LDSN
SHPHF